Skip to main content
SpringerLink
Log in

Clinicians should remain vigilant for serious infection in patients treated with anakinra,

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Galloway JB, Hyrich KL, Mercer LK, Dixon WG, Watson KD, Lunt M, Symmons DP.The risk of serious infections in patients receiving anakinra for rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register. Rheumatology: 12 Apr 2011. Available from: URL: http://dx.doi.org/10.1093/rheumatology/ker146

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Clinicians should remain vigilant for serious infection in patients treated with anakinra,. React. Wkly. 1354, 3 (2011). https://doi.org/10.2165/00128415-201113540-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201113540-00006

Keywords

Search

Navigation